Herceptin

Latest stories

1d
FOX Business
Regeneron Pharmaceuticals, Inc. vs. Rochefrom biosimilars -- generic forms of complex biologic drugs -- in the near futu
Regeneron Pharmaceuticals, Inc. vs. Roche
FOX Business / Posted yesterday
from biosimilars -- generic forms of complex biologic drugs -- in the near future. Sales of cancer therapies Rituxan and Herceptin are still growing by single digits despite first earning FDA approval in 1997 and 1998, respectively. In the first... Read more
1d
FOX Business
Regeneron Pharmaceuticals, Inc. vs. Rochefrom biosimilars -- generic forms of complex biologic drugs -- in the near futu
Regeneron Pharmaceuticals, Inc. vs. Roche
FOX Business / Posted yesterday
from biosimilars -- generic forms of complex biologic drugs -- in the near future. Sales of cancer therapies Rituxan and Herceptin are still growing by single digits despite first earning FDA approval in 1997 and 1998, respectively. In the first... Read more
1d
The Economic Times
Biotech giant Roche takes NPPA to court over cap on injection priceceiling price it fixed for breast cancer injection trastuzumab. The Swiss compa
Biotech giant Roche takes NPPA to court over cap on injection price
The Economic Times / Posted yesterday
ceiling price it fixed for breast cancer injection trastuzumab. The Swiss company sells the injection under the brand name Herceptin internationally and Herclon in India. On May 9, the NPPA issued a notification capping the price of trastuzumab... Read more
1d
Scoop.co.nz
Dunne Speaks: Meanwhile, after the Budget ...and may not be able to be funded within PHARMAC’s existing budget and criteria.
Dunne Speaks: Meanwhile, after the Budget ...
Scoop.co.nz / Posted yesterday
and may not be able to be funded within PHARMAC’s existing budget and criteria. The debate over the breast cancer drug Herceptin in 2007-09 was one such example. The upshot was that the government made specific funding available for Herceptin... Read more
2d
News-Medical-Net
First large-scale proteogenomic study helps pinpoint genes that drive breast cancerand physicians hope to identify more druggable kinase proteins in addition to H
First large-scale proteogenomic study helps pinpoint genes that drive breast cancer
News-Medical-Net / Posted 2 days ago
and physicians hope to identify more druggable kinase proteins in addition to HER2, which can be targeted with trastuzumab (Herceptin) but only in 20 percent of breast cancers that overexpress the HER2 protein. In this study, the researchers... Read more
3d
Market Watch
The staggering cost of breast cancerfor them, or pony up a high copay if your insurance covers them, when you pick
The staggering cost of breast cancer
Market Watch / Posted 3 days ago
for them, or pony up a high copay if your insurance covers them, when you pick up the prescription. A one-year course of Herceptin (a drug added to chemotherapy) costs $64,000 before insurance. There are also myriad treatment options that breast... Read more
5d
The Financial Express
How to be financially prepared to deal with critical illnessfactor that compounds problems is the rising costs of healthcare and the rising
How to be financially prepared to deal with critical illness
The Financial Express / Posted 5 days ago
factor that compounds problems is the rising costs of healthcare and the rising incidence of such illnesses. For example, Herceptin, an effective drug for breast cancer treatment costs around Rs 75,000 to Rs 1 lakh a vial and patients generally... Read more
6d
Chattanooga Times Free Press
Dalton woman with cancer competing in Ironman 70.3 in memory of her late songone, its pace is at least slowed. "I take six Tykerb pills a day," she said.
Dalton woman with cancer competing in Ironman 70.3 in memory of her late son
Chattanooga Times Free Press / Posted 6 days ago
gone, its pace is at least slowed. "I take six Tykerb pills a day," she said. "Every three weeks I have an infusion of Herceptin. I'll have to have treatments for the rest of my life." Her life's prognosis is all over the map. Two years. Five... Read more
7d
The Economic Times
Roche’s reputation at stake if Avastin biosimilar approved without trial: Kapil Sibalimposed conditions on Indian biotech drug makers Biocon and Mylan to sell copie
Roche’s reputation at stake if Avastin biosimilar approved without trial: Kapil Sibal
The Economic Times / Posted 7 days ago
imposed conditions on Indian biotech drug makers Biocon and Mylan to sell copies of the Swiss company's breast cancer drug, Herceptin (trastuzumab)— a move frowned upon by health activists who argued that it would affect the availability and... Read more
7d
Northern Star
'Terrifying ordeal': Mum lives fear-free life for two boystold I would need six months of chemo, six weeks of radiation and an additional
'Terrifying ordeal': Mum lives fear-free life for two boys
Northern Star / Posted 7 days ago
told I would need six months of chemo, six weeks of radiation and an additional 12 months of an oncology treatment called Herceptin. Ultimately it was my choice as to which treatment I had but I knew how much chemo can destroy a body. I was... Read more
6 related stories
7d
The Daily Mercury
'Terrifying ordeal': Mum lives fear-free life for two boystold I would need six months of chemo, six weeks of radiation and an additional
'Terrifying ordeal': Mum lives fear-free life for two boys
The Daily Mercury / Posted 7 days ago
told I would need six months of chemo, six weeks of radiation and an additional 12 months of an oncology treatment called Herceptin. Ultimately it was my choice as to which treatment I had but I knew how much chemo can destroy a body. I was... Read more
6 related stories
7d
Toowoomba Chronicle
'Terrifying ordeal': Mum lives fear-free life for two boystold I would need six months of chemo, six weeks of radiation and an additional
'Terrifying ordeal': Mum lives fear-free life for two boys
Toowoomba Chronicle / Posted 7 days ago
told I would need six months of chemo, six weeks of radiation and an additional 12 months of an oncology treatment called Herceptin. Ultimately it was my choice as to which treatment I had but I knew how much chemo can destroy a body. I was... Read more
6 related stories
7d
Queensland Times
'Terrifying ordeal': Mum lives fear-free life for two boystold I would need six months of chemo, six weeks of radiation and an additional
'Terrifying ordeal': Mum lives fear-free life for two boys
Queensland Times / Posted 7 days ago
told I would need six months of chemo, six weeks of radiation and an additional 12 months of an oncology treatment called Herceptin. Ultimately it was my choice as to which treatment I had but I knew how much chemo can destroy a body. I was... Read more
6 related stories
7d
The Morning Bulletin
'Terrifying ordeal': Mum lives fear-free life for two boystold I would need six months of chemo, six weeks of radiation and an additional
'Terrifying ordeal': Mum lives fear-free life for two boys
The Morning Bulletin / Posted 7 days ago
told I would need six months of chemo, six weeks of radiation and an additional 12 months of an oncology treatment called Herceptin. Ultimately it was my choice as to which treatment I had but I knew how much chemo can destroy a body. I was... Read more
6 related stories
7d
News Mail
'Terrifying ordeal': Mum lives fear-free life for two boystold I would need six months of chemo, six weeks of radiation and an additional
'Terrifying ordeal': Mum lives fear-free life for two boys
News Mail / Posted 7 days ago
told I would need six months of chemo, six weeks of radiation and an additional 12 months of an oncology treatment called Herceptin. Ultimately it was my choice as to which treatment I had but I knew how much chemo can destroy a body. I was... Read more
6 related stories
7d
Daily Examiner
'Terrifying ordeal': Mum lives fear-free life for two boystold I would need six months of chemo, six weeks of radiation and an additional
'Terrifying ordeal': Mum lives fear-free life for two boys
Daily Examiner / Posted 7 days ago
told I would need six months of chemo, six weeks of radiation and an additional 12 months of an oncology treatment called Herceptin. Ultimately it was my choice as to which treatment I had but I knew how much chemo can destroy a body. I was... Read more
6 related stories
8d
Newsmax
Precision Cancer Treatment May Extend Livesthe lung cancer drug erlotinib (Tarceva), the melanoma drug dabrafenib (Tafinla
Precision Cancer Treatment May Extend Lives
Newsmax / Posted 8 days ago
the lung cancer drug erlotinib (Tarceva), the melanoma drug dabrafenib (Tafinlar), and the breast cancer drug trastuzumab (Herceptin). All inhibit cancer by interfering with the signals that spur tumor growth, Hyman said. In this study,... Read more
3 related stories
8d
Manchester Evening News
Cancer drug trialled at The Christie won't be available on NHS - despite being 'twice as effective at eradicating tumours'cell does not receive messages telling it to grow. Perjeta is licensed for use
Cancer drug trialled at The Christie won't be available on NHS - despite being 'twice as effective at eradicating tumours'
Manchester Evening News / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. Perjeta costs £2,395 per 420mg vial (excluding VAT). The... Read more
20 related stories
8d
Daily Telegraph
Breast cancer drug rejected despite doubling in tumour destructionwith current treatment. Such complete responses were seen in 39 per cent of ca
Breast cancer drug rejected despite doubling in tumour destruction
Daily Telegraph / Posted 8 days ago
with current treatment. Such complete responses were seen in 39 per cent of cases, when the drug was combined with Herceptin and standard chemotherapy compared with 21.5 per cent for those only on Herceptin and chemotherapy. Additional... Read more
20 related stories
8d
Swissinfo
Roche’s Perjeta Fails to Win U.K. Backing on ‘Uncertain’ BenefitFriday, the National Institute for Health and Care Excellence said the medicine
Roche’s Perjeta Fails to Win U.K. Backing on ‘Uncertain’ Benefit
Swissinfo / Posted 8 days ago
Friday, the National Institute for Health and Care Excellence said the medicine isn’t recommended for use with Roche’s Herceptin and chemotherapy before surgery when the cancer is locally advanced, inflammatory or at high risk of... Read more
8d
Harrow Times
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
Harrow Times / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
This is West Country
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
This is West Country / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
Gazette News
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
Gazette News / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
Bolton News
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
Bolton News / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
Wandsworth Guardian
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
Wandsworth Guardian / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
St Albans & Harpenden Review
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
St Albans & Harpenden Review / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
Croydon Guardian
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
Croydon Guardian / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
Hampshire Chronicle
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
Hampshire Chronicle / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
This is Oxfordshire
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
This is Oxfordshire / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
Lancashire Telegraph
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
Lancashire Telegraph / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
Channel NewsAsia
Roche breast cancer drug Perjeta rejected by UK cost agencyabout its long-term benefits. Perjeta is designed for use in combination with
Roche breast cancer drug Perjeta rejected by UK cost agency
Channel NewsAsia / Posted 8 days ago
about its long-term benefits. Perjeta is designed for use in combination with chemotherapy and Roche's older drug Herceptin, or trastuzumab, before breast cancer surgery to shrink the cancer so that it becomes operable. "In order to be... Read more
20 related stories
8d
Northern Echo
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
Northern Echo / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
West Moreland Gazette
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
West Moreland Gazette / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
Kingston Guardian
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
Kingston Guardian / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
Oxford Mail
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
Oxford Mail / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
Streatham Guardian
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
Streatham Guardian / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
Bury Times
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
Bury Times / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
Gazette
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
Gazette / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
8d
guardian-series
Breast cancer drug rejected for NHS despite doubling destruction of tumourscell does not receive messages telling it to grow. Perjeta is licensed for use
Breast cancer drug rejected for NHS despite doubling destruction of tumours
guardian-series / Posted 8 days ago
cell does not receive messages telling it to grow. Perjeta is licensed for use in combination with the current treatment Herceptin (trastuzumab) and chemotherapy for earlier-stage cancer. In the new guidance for England, Nice said there was a... Read more
20 related stories
9d
Irish Examiner
Cancer trials to save Exchequer €6.5m while supporting 230 jobsHennessy, who’s clinical lead with Cancer Trials Ireland says they also give pa
Cancer trials to save Exchequer €6.5m while supporting 230 jobs
Irish Examiner / Posted 9 days ago
Hennessy, who’s clinical lead with Cancer Trials Ireland says they also give patients access to the latest drugs, like Herceptin when it was trialled;”Through Cancer trials Ireland, women in Ireland got access to that drug several years before... Read more
10d
Business Wire
Synthon advances clinical evaluation of anti-HER2 ADC SYD985 in an expanded cohort of HER2-positive metastatic breast cancer patientsdurable responses were observed in patients whose cancers were refractory to HE
Synthon advances clinical evaluation of anti-HER2 ADC SYD985 in an expanded cohort of HER2-positive metastatic breast cancer patients
Business Wire / Posted 10 days ago
durable responses were observed in patients whose cancers were refractory to HER2-targeted agents, including trastuzumab (Herceptin®*) and trastuzumab emtansine (Kadcyla®*), following treatment with SYD985 at doses from 1.2 mg/kg... Read more
11d
FOX News
FDA approves new targeted breast cancer drugtargets tumor cells while sparing healthy ones. The drug Kadcyla (kad-SY'-luh)
FDA approves new targeted breast cancer drug
FOX News / Posted 11 days ago
targets tumor cells while sparing healthy ones. The drug Kadcyla (kad-SY'-luh) from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the... Read more
12d
chroniclelive
Meet the mum on a mission to eliminate the stigma around 'dirty word' cancercould be further form the truth. The charity’s creator had a double mastectomy
Meet the mum on a mission to eliminate the stigma around 'dirty word' cancer
chroniclelive / Posted 12 days ago
could be further form the truth. The charity’s creator had a double mastectomy, six months of chemotherapy and had to take Herceptin for a year. She then went through a series of breast reconstructions following her treatment. “I was just winging... Read more
12d
Detroit Free Press
Why heart health is vital if you have breast cancerDoxorubicin, Epirubicin, Idarubicin, Mitoxantrone and Valrubicin), but other dr
Why heart health is vital if you have breast cancer
Detroit Free Press / Posted 12 days ago
Doxorubicin, Epirubicin, Idarubicin, Mitoxantrone and Valrubicin), but other drugs can also impact your ticker, including herceptin and perjeta. Undergoing radiation therapy? If the targeted area includes the heart—as it undoubtedly does when your... Read more
12d
The Economic Times
Roche moves court to block copies of cancer drug Avastin, A La Herceptinpathways for copies of popular biotech drugs is similar to the aggressive postu
Roche moves court to block copies of cancer drug Avastin, A La Herceptin
The Economic Times / Posted 12 days ago
pathways for copies of popular biotech drugs is similar to the aggressive posture it took to defend its breast cancer drug Herceptin (trastuzumab), where it sued the drug regulator alongside Biocon, Mylan and Reliance Life Sciences. Roche did not... Read more
16d
News-Medical-Net
Single breath-hold for more than five minutes could make targeted radiotherapy feasibleso there is no risk attached." Of all 15 patients undergoing radiotherapy, 13
Single breath-hold for more than five minutes could make targeted radiotherapy feasible
News-Medical-Net / Posted 16 days ago
so there is no risk attached." Of all 15 patients undergoing radiotherapy, 13 also had chemotherapy and 2 were taking Herceptin. The Birmingham team believe that being able to assist patients in achieving a single breath-hold could greatly... Read more
17d
Eye Witness News
Health minister aims to reduce cost of cancer treatmentschool kids per annum forever.” He has now turned his attention to breast canc
Health minister aims to reduce cost of cancer treatment
Eye Witness News / Posted 17 days ago
school kids per annum forever.” He has now turned his attention to breast cancer patients on treatment known commonly as Herceptin, which costs R500,000 for a year's treatment. “Do you imagine how painful is it to look at a woman suffering from... Read more
18d
Channel NewsAsia
South Africa negotiating with Roche to cut cancer drug pricesCAPE TOWN: South Africa is in talks with pharmaceutical firm Roche to reduce th
South Africa negotiating with Roche to cut cancer drug prices
Channel NewsAsia / Posted 18 days ago
CAPE TOWN: South Africa is in talks with pharmaceutical firm Roche to reduce the price of its breast cancer drug Herceptin, which cost 500,000 rand (US$32,745) a year to treat one person and was unaffordable to most women, the health minister said on... Read more
18d
AllAfrica.com
Minister Aaron Motsoaledi - Health Dept Budget Vote 2016which I had foreseen is here with us. If you have breast cancer and you need t
Minister Aaron Motsoaledi - Health Dept Budget Vote 2016
AllAfrica.com / Posted 18 days ago
which I had foreseen is here with us. If you have breast cancer and you need treatment with Trastuzumab, known commonly as Herceptin you must part with close to R500 000.00 for a year's treatment: These are figures out of this world which even... Read more
18d
Channel NewsAsia
South African health authorities wants Roche to reduce cancer medication pricesCAPE TOWN: South Africa is negotiating with pharmaceutical company Roche to red
South African health authorities wants Roche to reduce cancer medication prices
Channel NewsAsia / Posted 18 days ago
CAPE TOWN: South Africa is negotiating with pharmaceutical company Roche to reduce the price of its breast cancer drug Herceptin, which cost 500,000 rand (US$32,745) a year to treat one person and was unaffordable to most women, the health minister... Read more
More

People in this news